Keywords: CSL, 2H10, Type 2 diabetes, Animal model, Drug candidate

Animal models show CSL drug candidate is research breakthrough in diabetes

Article | 28 September 2012

Print This

Australia’s CSL Limited (ASX: CSL) has developed a new drug candidate – dubbed 2H10 - that is able ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in